Surgical Site Infection Prevention: Which Bundle Elements Have the Evidence

Why Surgical Site Infection Matters

Surgical site infection is among the most common and costly complications of an operation. A 2023 narrative review in JAMA estimates that roughly 0.5% to 3% of surgical patients develop an infection at or adjacent to the incision. Rates climb higher in abdominal and emergency procedures.

The burden is uneven across settings. World Health Organization figures place SSI incidence near 1.2% to 5.2% in high-income countries and around 10.8% in low- and middle-income settings. In every setting, infection lengthens recovery and increases readmission.

Prevention has converged on the care bundle — several evidence-based steps applied together for every case. The appeal is intuitive: layer independent safeguards, and drive infection down. The difficulty is that bundles often mix rigorously tested steps with weakly supported ones.

This review sorts common bundle elements by the strength of their evidence. It asks a practical question: which components carry real trial support, and which persist mainly by habit?

A Practical Taxonomy of Surgical Site Infection Prevention

Bundle elements fall into three working domains. Antimicrobial measures act on the bacteria directly. Antiseptic and skin-preparation measures reduce the skin’s bacterial load. Physiologic and mechanical measures protect host defences or the wound edge.

The table compares nine core approaches against their best available evidence. Each row names the anchoring study, its design and size, the measured effect on infection, and a confidence tier.

Two patterns stand out. The largest effects come from antimicrobial steps and alcohol-based skin preparation. The weakest signals cluster among adjuncts that were added to bundles later.

Category A: Antimicrobial Measures

Antimicrobial measures carry the strongest and most consistent evidence in the field. They also anchor almost every published bundle.

Systemic prophylaxis, correctly timed

Giving a prophylactic antibiotic before incision is firmly established. In a prospective study of 2,847 patients, administration within two hours before incision was associated with the lowest infection rate.

What remains debated is the precise minute-window. A meta-analysis of 54,552 patients found no clear differential between intervals inside the 120-minute pre-incision window. So “before incision, at adequate tissue levels” is what the evidence supports; a single optimal minute is not.

Oral antibiotics in colorectal surgery

In elective colorectal surgery, adding oral antibiotics to intravenous prophylaxis lowers infection. A 2026 meta-analysis of 17 randomized trials associated combined mechanical and oral antibiotic preparation with fewer infections (OR 0.44, 95% CI 0.37–0.54).

The signal is specifically about the oral antibiotics. Network analyses find that mechanical bowel preparation alone confers no infection benefit, and WHO advises against using it without oral antibiotics.

Staphylococcus aureus decolonization

Screening surgical patients for S. aureus nasal carriage and decolonizing carriers has strong randomized support. In a trial of 917 patients, mupirocin nasal ointment with chlorhexidine washing reduced S. aureus infection (RR 0.42, 95% CI 0.23–0.75), with the largest effect for deep infection (RR 0.21).

The benefit is targeted, not universal. An earlier trial applying mupirocin to all patients regardless of carriage showed no overall reduction. Decolonizing confirmed carriers — routine in cardiac and orthopedic surgery — is the supported strategy.

Triclosan-coated sutures

Antibacterial sutures show a consistent but modest effect. A 2024 meta-analysis of 11 randomized trials, covering 10,234 patients, associated triclosan-coated sutures with fewer infections (OR 0.84, 95% CI 0.75–0.93), an absolute difference of roughly two percentage points.

Larger pooled analyses, including one of 31 trials, point the same direction. The effect is real but small, and clearest for abdominal fascial closure rather than for surgery in general.

Category B: Skin and Antiseptic Measures

This domain contains one of the strongest bundle elements and one of the weakest. Separating them depends on distinguishing the antiseptic step from the specific product.

Alcohol-based skin antisepsis

Preparing the skin with an alcohol-based antiseptic before incision is well supported. A randomized trial of 849 patients found that chlorhexidine-alcohol reduced infection compared with aqueous povidone-iodine (RR 0.59, 95% CI 0.41–0.85).

The design carried a confounder worth naming. The chlorhexidine arm used alcohol; the povidone-iodine arm did not. The comparison therefore blended the antiseptic with its carrier.

Which agent — chlorhexidine or povidone-iodine

Once both agents are formulated in alcohol, the gap narrows. A 2024 cluster-randomized trial of 3,360 cardiac and abdominal patients found povidone-iodine in alcohol noninferior to chlorhexidine in alcohol (5.1% vs 5.5% overall).

Pooled data still modestly favor chlorhexidine for overall infection, but the alcohol carrier appears to do much of the work. Using an alcohol-based agent is the established step; the specific agent is a smaller, contested question.

Hair removal

The evidence here is mainly about what not to do. Guidelines advise against shaving with a razor, which can create micro-abrasions that seed infection. Where removal is necessary, clippers are preferred, and leaving hair in place is acceptable.

Preoperative bathing

Whole-body washing before surgery is reasonable hygiene, but the antiseptic adds little. A Cochrane review of seven trials and over 10,000 patients found no advantage for chlorhexidine over placebo (RR 0.91, 95% CI 0.80–1.04).

A separate comparison against plain bar soap showed no difference either (RR 1.02, 95% CI 0.57–1.84). Patients should bathe; whether the product is antiseptic or ordinary soap does not measurably change infection.

Category C: Physiologic and Mechanical Measures

These adjuncts range from moderately supported to genuinely unsettled. Several remain in bundles despite thin or conflicting trial evidence.

Perioperative normothermia

Keeping patients warm has plausible mechanism and randomized support, though the anchor trial is small. In 200 colorectal patients, maintaining normothermia reduced wound infection (6% vs 19%).

The trial is decades old and single-center, so the precise effect size is uncertain. Even so, the direction is consistent, and guidelines endorse active warming.

Glycemic control

Controlling perioperative hyperglycemia is guideline-recommended, including a common target below 200 mg/dL. The supporting evidence is more observational and mechanistic than trial-based. Intensive control is not advised, because tight targets raise hypoglycemia risk without a clear infection gain.

Supplemental oxygen (high inspired fraction)

High inspired oxygen illustrates how evidence can shift. WHO initially issued a strong recommendation, then downgraded it to conditional in 2018 after reassessing conflicting trials and potential harms. It sits among the contested elements rather than the settled ones.

Wound-edge protectors

Plastic wound-edge protectors are the clearest example of conflicting evidence. The largest single trial, ROSSINI, randomized 760 laparotomy patients and found no reduction (24.7% vs 25.4%; OR 0.97, 95% CI 0.69–1.36).

Pooled analyses tell a different story. A meta-analysis of 16 trials reported a reduction (RR 0.65, 95% CI 0.51–0.83), but its estimate was weighted toward older, lower-quality studies. When trial quality is weighed, the apparent benefit largely dissolves.

Comparative Analysis

Reorganizing the nine approaches by evidence tier clarifies the picture. Four elements carry strong support: timed systemic prophylaxis, alcohol-based skin antisepsis, targeted decolonization in carriers, and oral antibiotics in colorectal surgery.

A middle tier is moderately supported: normothermia, triclosan-coated sutures, and glycemic control. These likely help, but the effect sizes are smaller or the underlying trials older.

A third tier is contested or unsupported: the specific antiseptic agent, wound-edge protectors, high inspired oxygen, chlorhexidine bathing over plain soap, and mechanical bowel preparation alone. Each rests on conflicting or null data.

One observation ties the tiers together. The strong elements are simple and inexpensive. Much of what enlarges a bundle belongs to the weaker tiers, where the marginal return is small and, in a few cases, absent.

Quality and Consistency of the Evidence

Strength of evidence varies sharply by element and by outcome. The tiers below reflect both the size of the effect and the quality of the studies behind it.

• Strong. Timed systemic antibiotic prophylaxis; alcohol-based skin antisepsis; targeted S. aureus decolonization; oral antibiotics in colorectal surgery — anchored by large randomized trials and network meta-analyses.
• Moderate. Perioperative normothermia; triclosan-coated sutures; glycemic control — consistent direction, but small or dated trials, or mainly observational support.
• Weak or contested. Chlorhexidine versus povidone-iodine agent choice; wound-edge protectors; high inspired oxygen; chlorhexidine bathing versus soap; mechanical bowel preparation alone — conflicting trials, quality-dependent pooled estimates, or null results.

Recurring quality issues shape these tiers: a single small trial (normothermia), a confounded comparison (skin antisepsis), a large null trial set against positive but weaker pooled data (wound-edge protectors), and a guideline reversal (oxygen).

Practical Implications

The evidence supports concentrating effort on a small, verified core. That means the correct antibiotic given before incision, an alcohol-based skin preparation, and screening with decolonization of S. aureus carriers in cardiac and orthopedic cases.

In elective colorectal surgery, the evidence supports adding oral antibiotics to intravenous prophylaxis. Maintaining normothermia and controlling perioperative hyperglycemia are reasonable, and triclosan sutures are a defensible option for abdominal fascial closure.

The evidence does not support relying on antiseptic bathing over plain soap for efficacy, nor using mechanical bowel preparation alone. Wound-edge protectors and high inspired oxygen are best treated as unsettled.

A reasonable inference follows. Auditing compliance with the strong elements tends to return more than appending weakly supported ones. Bundles perform best when built from graded components rather than from every plausible measure.

Article Information and References

1. World Health Organization. Global Guidelines for the Prevention of Surgical Site Infection, 2nd ed. Geneva: WHO; 2018. Available at: who.int/publications/i/item/9789241550475
2. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784–791. DOI: https://doi.org/10.1001/jamasurg.2017.0904
3. Seidelman JL, Mantyh CR, Anderson DJ. Surgical site infection prevention: a review. JAMA. 2023;329(3):244–252. DOI: https://doi.org/10.1001/jama.2022.24075
4. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev. 2015;(2):CD004985. DOI: https://doi.org/10.1002/14651858.CD004985.pub5
5. Mihaljevic AL, Müller TC, Kehl V, Friess H, Kleeff J. Wound edge protectors in open abdominal surgery to reduce surgical site infections: a systematic review and meta-analysis. PLoS One. 2015;10(3):e0121187. DOI: https://doi.org/10.1371/journal.pone.0121187
6. Systematic review and meta-analysis comparing surgical site infection in abdominal surgery between triclosan-coated and uncoated sutures. Hernia. 2024. DOI: https://doi.org/10.1007/s10029-024-03045-5
7. Mechanical and oral antibiotics bowel preparation reduce the risk of surgical site infections and anastomotic leakage in colorectal surgery: a GRADE-based meta-analysis and trial sequential analysis. Front Med (Lausanne). 2026. DOI: https://doi.org/10.3389/fmed.2026.1788204
8. Preoperative oral antibiotics with and without mechanical bowel preparation on surgical site infection in colorectal surgery: a network meta-analysis and GRADE assessment. Ann Surg Open. DOI: https://doi.org/10.1097/as9.0000000000000175
9. Darouiche RO, Wall MJ Jr, Itani KMF, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18–26. DOI: https://doi.org/10.1056/NEJMoa0810988
10. Widmer AF, Atkinson A, Kuster SP, et al. Povidone iodine vs chlorhexidine gluconate in alcohol for preoperative skin antisepsis: a randomized clinical trial. JAMA. 2024;332(7):541–549. DOI: https://doi.org/10.1001/jama.2024.8531
11. Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9–17. DOI: https://doi.org/10.1056/NEJMoa0808939
12. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med. 1996;334(19):1209–1215. DOI: https://doi.org/10.1056/NEJM199605093341901
13. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326(5):281–286. DOI: https://doi.org/10.1056/NEJM199201303260501
14. Pinkney TD, Calvert M, Bartlett DC, et al. Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial). BMJ. 2013;347:f4305. DOI: https://doi.org/10.1136/bmj.f4305